Four Corners (FCPT) Q4 2025 earnings review
Record Volume and Yield Expansion, Diluted by Equity
Four Corners delivered a strong operational quarter with Rental Revenue rising 11.6% YoY to $67.8M. The company aggressively deployed capital, acquiring $95M in properties at a 7.0% yield—its highest yield of the year. However, this growth was heavily funded by equity (share count +9.6%), which muted the bottom-line benefit; AFFO per share grew only 2.2% to $0.45. With leverage at a conservative 4.9x against a 6.0x ceiling, FCPT enters 2026 with significant dry powder but faces the challenge of translating volume into meaningful per-share acceleration.
🐂 Bull Case
Acquisition cap rates expanded to 7.0% in Q4, up from 6.7-6.8% earlier in the year. This 20-30bps improvement is critical for maintaining investment spreads in a higher-rate environment.
Net debt to Adjusted EBITDAre stands at 4.9x (inclusive of forward equity), well below the 6.0x upper limit. This 'over-equitized' position gives management approximately $350M+ of debt capacity to fund 2026 growth without immediate equity issuance.
🐻 Bear Case
The reliance on ATM equity to fund growth has kept per-share compounding sluggish. While Rental Revenue grew 11.6% and Net Income 12.5%, the 9.6% increase in share count suppressed AFFO/share growth to just $0.01 YoY.
General & Administrative expenses rose 9.1% YoY to $6.2M. While Cash G&A as a % of revenue is stable (6.5%), the absolute dollar increase is eating into the margin benefits of scale.
⚖️ Verdict: 🟢
Stable. FCPT is executing its playbook perfectly: raising equity, buying accretive assets, and diversifying. The 7.0% yield in Q4 is a highlight. However, investors looking for explosive per-share growth will be disappointed by the dilution. It is a defensive, low-leverage compounder.
Key Themes
Major Pivot to Medical Retail
Accelerating. In a significant shift from its restaurant roots, Medical Retail accounted for 48% of Q4 acquisition volume by purchase price. This is a sharp increase from prior quarters and FY averages (24% for FY25), signaling a strategic push to diversify tenant base and likely capture larger transaction sizes.
Acquisition Ramp & Yield Expansion
Accelerating. FCPT deployed $95M in Q4, the highest quarterly volume of 2025, bringing the full year to nearly $318M. Crucially, the weighted average cash yield rose to 7.0%, breaking out of the 6.7%-6.8% range seen in Q1-Q3. This improved pricing power suggests management is successfully navigating the bid-ask spread with sellers.
High Equity Reliance (Dilution)
Stable. The company sold over 6 million shares in 2025 via ATM, raising $172.7M. While this keeps the balance sheet pristine (4.9x leverage), the weighted average diluted shares outstanding jumped from 97.2M in 24Q4 to 106.5M in 25Q4. This 9.6% dilution hurdle requires double-digit asset growth just to maintain low-single-digit AFFO growth.
Portfolio Resilience
Stable. Operational metrics remain rock-solid. Occupancy held at 99.6%, and rent collections for the year were 99.8%. The weighted average remaining lease term on new acquisitions was 9.8 years, contributing to a portfolio average of 6.9 years.
Other KPIs
Accelerating. Up 11.6% YoY and 2.0% sequentially vs Q3 ($66.5M). The sustained double-digit YoY growth reflects the cumulative effect of the $318M deployed throughout 2025.
Stable. Up $0.01 (+2.2%) vs 24Q4 and flat vs 25Q3. The lack of sequential growth despite record acquisitions highlights the impact of share issuance timing and quantity.
Stable/Low. Reported at 5.1x, or 4.9x when including unsettled forward equity. This is significantly below the company's long-term target of 5.5x-6.0x (and Q3 stated range of 5.0-6.0x), providing massive capacity for debt-funded growth in 2026.
Guidance
Stable. Includes cash, forward sale proceeds, and revolver capacity. Management notes they enter 2026 with an 'over-equitized capital position,' implying they can fund a significant portion of the year's pipeline with debt while drifting leverage up toward the 6.0x target.
Key Questions
Yield Sustainability
Acquisition yields jumped to 7.0% in Q4 from a steady 6.7-6.8% in the first three quarters. Is this a structural repricing of your target assets, or a mix shift benefit from the heavy Medical Retail volume?
Debt vs Equity in 2026
With leverage at 4.9x and a stated target ceiling of 6.0x, do you intend to pause ATM issuance in 2026 and let leverage rise to drive better per-share AFFO growth?
Medical Retail Strategy
Medical Retail comprised nearly half of Q4 investment volume. Are you structurally increasing the allocation to this sector, and how does its risk/return profile compare to your core restaurant assets?